EGFR and non-small cell lung carcinoma: In this study, we showed that the elevated TRIB3 participates in the pathogenesis and progression of NSCLC by enhancing EGFR recycling and stability, not only for the WT-EGFR, but also for the activating and “gatekeeper” mutants.